COLLABORATIONS

COLLABORATIONS  (last 10 years): (companies are in italics and underlined)

International

University of Albany, Sunny, NY, USA, NanoBioscience, College of Nanosale Science and Engineering (2013-)

Prof Susan Sharfstein, CMV promoter and CHO epigenetics,http://cnse.albany.edu/AboutUs/FacultyStaff/Faculty/SusanSharfstein.aspx

Cancer Research UK, Cambridge Research Institute (2012-)

Dr Jason S. Carroll, Principal Investigator, chromatin IP tech, breast cancer diagnostics, http://www.carroll-lab.org.uk/members

Laboratory of Bioseparation Sciences, Insbruck, Austria. (2010-)

Prof András Guttman, Antibody glycosylation analysis, tech development http://www.hlbs.org/about_pi.php

Biosystems International Ltd. (2010-2012)

Prof István Kurucz, ex CSO, monoclonal antibody development, http://www.biosys-intl.com/?lg=en

University of Newcastle upon Tyne, UK, Institute for Cell and Molecular Biosciences ICaMB (1993-2006)

Prof Monica A. Hughes, ex Head of School and Director of Institute, retired, molecular genetics

Prof. Jeremy H. Lakey, Protein engineering, structural biochemistry,http://www.ncl.ac.uk/camb/staff/profile/jeremy.lakey

Prof Robert N. Lightowlers, Director of Institute, BIACORE,http://www.ncl.ac.uk/camb/staff/profile/robert.lightowlers

Dr. Joe Gray, Molecular Biology Unit, mass spectrometry, http://www.ncl.ac.uk/camb/facilities/mbu.htm

ORLA Protein Technologies Ltd. (2002-2005)

Prof. Jeremy H. Lakey, CSO, bionanosensor engineering, http://www.orlaproteins.com

Cambridge Center for Protein Engineering, MRC Center, Cambridge, UK (2002)

Sir Prof Alan R. Fersht, FRS, directed molecular evolution,http://www.mrc.ac.uk/Ourresearch/Unitscentresinstitutes/UnitCentreDetails/MRC002122

ELIZANOR Polymer, LLC (2006-2008)

Prof John Hartmann, CEO, polymeric nanoparticle-based drug delivery, http://www.elizanor.com/

Rutgers, The State University of New Jersey, Department of Pharmaceutics (2006-2008)

Prof Tamara Minko, Chair, targeted drug delivery, http://ceutics.rutgers.edu/minkohome.shtml

University of Nijmegen, Holland, Department of Biochemistry (2000)

Prof. Dr. Wilfried W. de Jong,  protein cross-linking enzymes and their substrates, retired

University of Ghent, Belgium, Department of Biochemistry, Physiology, and Microbiology (2000)

Prof. Jozef Van Beeumen, proteomics. http://www.lprobe.ugent.be/index.html

Hungary

Gedeon Richter Pharmaceuticals, Plc. Budapest, Hungary (2010-)

Dr. Zoltán Urbányi, Deputy Head of Bio-Analytical Department, cell line engineering, http://www.richter.hu

Institute of Enzymology, Hungarian Academy of Sciences, Budapest, Hungary (2013-)

Prof Beáta Vértessy, MHASc, ZFN genome engineering, http://www.enzim.hu/index.php?option=com_content&task=blogcategory&id=52&Itemid=190

Institute of Clinical Microbiology, Albert Szentgyörgyi Clinical Center, University of Szeged, Fac.Medicine (2013-)

Dr. Dezső Virók, vaccinomics, phage display, http://www.klinikaikozpont.u-szeged.hu/clinmicro/en/staff/staff/aniko-kuris.html

Internal

Medical and Health Science Center, University of Debrecen, Hungary

Department of Biochemistry and Molecular Biology (1998-)

Prof  Dr. László Fésüs, MHASc, TG2 mechanism and molecular biology,http://bmbi.med.unideb.hu/joomla15/index.php/en/staff/head-of-department

Prof Dr László Nagy, MHASc, antibody development, ChIP process development, http://nlab.med.unideb.hu/ln.htm

Research Center for Clinical Chemistry, Hungarian Academy of Sciences (2008-2009)

Prof Dr. László Muszbek, MHASc, protein cross-linking, http://crc.med.unideb.hu/lm.html

Department of Pathology (2012-)

Prof Dr Gábor Méhes, soluble receptor-based diagnostics development, http://pathol.med.unideb.hu/en/node/59